Clinical Trials Browser

Active not recruiting × INDUSTRY × AMG 757 × Clear all

NCT05361395 2026-03-03

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Phase 1 Active not recruiting

Bites and Stings, Lung Neoplasms

NCT06745323 2026-03-03

DeLLphi-309

Phase 2 Active not recruiting

Small Cell Lung Carcinoma

NCT05740566 2026-01-05

DeLLphi-304

Phase 3 Active not recruiting

509 enrolled 11 charts 1 FDA

Small Cell Lung Carcinoma

NCT06211036 2025-12-17

DeLLphi-305

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT06502977 2025-10-28

DeLLphi-307

Phase 2 Active not recruiting

Neoplasms, Neuroendocrine Tumors